MedTrace Logo

HbA1c and Outcomes in the Critically Ill

NCT02822976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2016-10-12

No results posted yet for this study

Summary

Background: Glycated hemoglobin A1c (HbA1c) has been linked to poor outcomes in the cardiac surgery, septic and critically ill patient population. It is a promising test to understand the complex relationship between glycemia, diabetes and outcomes in patients admitted to the intensive care unit.

Hypothesis: An elevated HbA1c value on admission to an intensive care unit (ICU) is associated with poor outcomes.

Conditions

  • Critical Illness

Sponsors & Collaborators

  • Roupen Hatzakorzian, MD

    lead OTHER

Principal Investigators

  • Roupen Hatzakorzian, MD, MSc · McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-07-31
Completion
2016-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02822976 on ClinicalTrials.gov